News
Tempus AI Shares Rise After Narrowing 2Q Loss on Higher Revenue
Shares of Tempus AI climbed after the company narrowed its net loss and logged higher-than-expected revenue in the second quarter, boosted by what Chief Executive Eric Lefkofsky called a significant reacceleration of clinical testing.
Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday. The AI-focused precision medicine and patient ...
2don MSN
In conjunction with its better-than-expected sales growth in the second quarter, Tempus AI raised its sales outlook for this ...
1d
Tempus AI Inc (TEM) reports an 89.6% revenue surge and strategic financial improvements, despite ongoing challenges in ...
Q2 2025 Management View Eric P. Lefkofsky, CEO, opened by stating, "Q2 was a fantastic quarter. As I mentioned in my letter, the company is hitting its stride as we approach our tenth anniversary, ...
In trading on the Nasdaq stock market as of 1:17 p.m. Central, Tempus' stock price was trading at $60.65, up 3.2% from the ...
Analysts expect the Chicago, Illinois-based company to report a quarterly loss at 25 cents per share, versus a year-ago loss ...
Baillie Gifford's Q2 2025 portfolio grew to $134B, focusing on growth stocks like NVIDIA and MercadoLibre. Click here to read ...
4don MSN
Although shares have retreated from their all-time high, those who bought shares one year ago are still looking at growth in ...
Shares in health technology group Tempus AI ($TEM) raced 7% higher today after its Q2 revenues surged on cancer testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback